IN2004DN03762A - - Google Patents

Download PDF

Info

Publication number
IN2004DN03762A
IN2004DN03762A IN3762DEN2004A IN2004DN03762A IN 2004DN03762 A IN2004DN03762 A IN 2004DN03762A IN 3762DEN2004 A IN3762DEN2004 A IN 3762DEN2004A IN 2004DN03762 A IN2004DN03762 A IN 2004DN03762A
Authority
IN
India
Prior art keywords
subjects
dosing
dose
post
subject
Prior art date
Application number
Other languages
English (en)
Inventor
T A Clayton
J R Everett
J C Lindon
J K Nicholson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0213786A external-priority patent/GB0213786D0/en
Priority claimed from GB0213895A external-priority patent/GB0213895D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of IN2004DN03762A publication Critical patent/IN2004DN03762A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
IN3762DEN2004 2002-06-14 2003-06-16 IN2004DN03762A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0213786A GB0213786D0 (en) 2002-06-14 2002-06-14 Metabolic phenotyping
GB0213895A GB0213895D0 (en) 2002-06-17 2002-06-17 Metabolic phenotyping

Publications (1)

Publication Number Publication Date
IN2004DN03762A true IN2004DN03762A (ja) 2010-01-08

Family

ID=29738094

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3762DEN2004 IN2004DN03762A (ja) 2002-06-14 2003-06-16

Country Status (15)

Country Link
US (2) US20050074745A1 (ja)
EP (1) EP1540560B1 (ja)
JP (1) JP4829496B2 (ja)
KR (1) KR20050012281A (ja)
AT (1) ATE502343T1 (ja)
AU (1) AU2003232406A1 (ja)
CA (1) CA2487836C (ja)
DE (1) DE60336403D1 (ja)
HK (1) HK1080167A1 (ja)
HR (1) HRP20041174A2 (ja)
IL (1) IL165329A0 (ja)
IN (1) IN2004DN03762A (ja)
NO (1) NO20045111L (ja)
RU (1) RU2004136317A (ja)
WO (1) WO2003107270A2 (ja)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050037515A1 (en) * 2001-04-23 2005-02-17 Nicholson Jeremy Kirk Methods for analysis of spectral data and their applications osteoporosis
US20040142496A1 (en) * 2001-04-23 2004-07-22 Nicholson Jeremy Kirk Methods for analysis of spectral data and their applications: atherosclerosis/coronary heart disease
WO2003017177A2 (en) * 2001-08-13 2003-02-27 Beyong Genomics, Inc. Method and system for profiling biological systems
ATE502343T1 (de) 2002-06-14 2011-04-15 Pfizer Metabolische phänotypisierung
CA2536388A1 (en) * 2003-08-20 2005-03-03 Bg Medicine, Inc. Methods and systems for profiling biological systems
US7534619B2 (en) * 2005-10-27 2009-05-19 Brandon Horn Method for determining metabolic type
US7899625B2 (en) * 2006-07-27 2011-03-01 International Business Machines Corporation Method and system for robust classification strategy for cancer detection from mass spectrometry data
JP5363984B2 (ja) * 2006-10-13 2013-12-11 メタボロン インコーポレイテッド 代謝年齢に関するバイオマーカー及びその使用方法
US20080286774A1 (en) * 2007-05-16 2008-11-20 The Regents Of The University Of California Real-time individualized therapy evaluation
US20100273203A1 (en) * 2009-04-23 2010-10-28 Board Of Trustees Of The University Of Arkansas Methods and compositions for detecting metabolites
US8660823B2 (en) * 2009-04-26 2014-02-25 Lester F. Ludwig Nonlinear and lie algebra structural analysis system for enzyme cascades, metabolic signal transduction, signaling pathways, catalytic chemical reaction networks, and immunology
GB0912744D0 (en) 2009-07-22 2009-08-26 Imp Innovations Ltd Methods and uses
GB0912685D0 (en) 2009-07-22 2009-08-26 Imp Innovations Ltd Methods
US8410064B2 (en) * 2009-08-24 2013-04-02 The Board Of Trustees Of The University Of Arkansas Classical cannabinoid metabolites and methods of use thereof
US8883218B2 (en) * 2010-03-26 2014-11-11 The Board Of Trustees Of The University Of Arkansas Anti-cancer nanoparticle compositions and methods of use
GB201012297D0 (en) * 2010-07-22 2010-09-08 Ge Healthcare Uk Ltd A system and method for automated biological cell assay data analysis
WO2012018535A2 (en) * 2010-07-26 2012-02-09 Wellness Indicators, Inc. Wellness panel
US9095598B2 (en) 2010-12-28 2015-08-04 The Board Of Trustees Of The University Of Arkansas Stilbenoid derivatives and their uses
US9535144B2 (en) 2012-06-01 2017-01-03 Liposcience, Inc. NMR quantification of TMAO
US9928345B2 (en) 2012-06-08 2018-03-27 Liposciences, Inc. Multiple-marker risk parameters predictive of conversion to diabetes
US9361429B2 (en) 2012-06-08 2016-06-07 Liposcience, Inc. Multi-parameter diabetes risk evaluations
US9470771B2 (en) 2012-06-08 2016-10-18 Liposcience, Inc. NMR measurements of NMR biomarker GlycA
RU2533846C1 (ru) * 2013-05-13 2014-11-20 Сергей Леонидович Устьянцев Способ определения энтропии в организме человека или животного
CN104215623B (zh) * 2013-05-31 2018-09-25 欧普图斯(苏州)光学纳米科技有限公司 面向多行业检测的激光拉曼光谱智能化辨识方法及系统
US9519823B2 (en) * 2013-10-04 2016-12-13 The University Of Manchester Biomarker method
US9953417B2 (en) 2013-10-04 2018-04-24 The University Of Manchester Biomarker method
CN107764848A (zh) * 2016-08-18 2018-03-06 中国科学院烟台海岸带研究所 一种基于代谢组学评价石斑鱼饲料利用的方法
CN108766587B (zh) * 2018-05-11 2022-05-03 北京诺道认知医学科技有限公司 一种基于指定药物构建给药数据库的方法及装置
CN108717876B (zh) * 2018-05-11 2022-05-20 大连诺道认知医学技术有限公司 一种基于指定药物构建给药数据库的方法及装置
CN108445112B (zh) * 2018-05-29 2021-03-16 云南中烟工业有限责任公司 一种烟叶烟气中4-(n-甲基-n-亚硝胺)-1-(3-吡啶基)-丁酮的检测方法
WO2020081326A1 (en) * 2018-10-15 2020-04-23 Olaris, Inc. Spectographic metabolite-signature for identifying a subject's susceptibility to drugs
WO2021072408A1 (en) * 2019-10-10 2021-04-15 Georgia Tech Research Corporation Label-free hematology and histopathology analysis using deep-ultraviolet microscopy
DK3809118T3 (da) * 2019-10-17 2023-09-18 Evonik Operations Gmbh Fremgangsmåde til at forudsige en egenskabsværdi af et materiale ved anvendelse af hovedkomponentanalyse
US20240077439A1 (en) * 2022-08-31 2024-03-07 Laboratory Corporation Of America Holdings Methods and Systems for Measuring Citrate and Creatinine Levels by NMR Spectroscopy
JPWO2025028546A1 (ja) * 2023-08-01 2025-02-06
CN120613144B (zh) * 2025-05-27 2026-02-03 中国科学院精密测量科学与技术创新研究院 一种基于血液nmr编辑谱的药物敏感度预测方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6658396B1 (en) * 1999-11-29 2003-12-02 Tang Sharon S Neural network drug dosage estimation
AU2001278075A1 (en) * 2000-07-28 2002-02-13 Lion Bioscience Ag Pharmacokinetic tool and method for predicting metabolism of a compound in a mammal
ATE502343T1 (de) 2002-06-14 2011-04-15 Pfizer Metabolische phänotypisierung

Also Published As

Publication number Publication date
IL165329A0 (en) 2006-01-15
HRP20041174A2 (en) 2005-06-30
CA2487836C (en) 2014-12-02
US20050074745A1 (en) 2005-04-07
JP2005534899A (ja) 2005-11-17
CA2487836A1 (en) 2003-12-24
WO2003107270A2 (en) 2003-12-24
KR20050012281A (ko) 2005-01-31
DE60336403D1 (de) 2011-04-28
US20090192721A1 (en) 2009-07-30
HK1080167A1 (zh) 2006-04-21
ATE502343T1 (de) 2011-04-15
EP1540560A2 (en) 2005-06-15
WO2003107270A3 (en) 2005-04-21
US8577617B2 (en) 2013-11-05
AU2003232406A1 (en) 2003-12-31
JP4829496B2 (ja) 2011-12-07
EP1540560B1 (en) 2011-03-16
RU2004136317A (ru) 2006-01-27
NO20045111L (no) 2005-01-12

Similar Documents

Publication Publication Date Title
IN2004DN03762A (ja)
BRPI0507858A (pt) arrasto suave para teste de pressão de formação
Iacobucci Mediation analysis and categorical variables: The final frontier
Smith et al. The relationship between critical velocity, maximal lactate steady-state velocity and lactate turnpoint velocity in runners
Alexander et al. Variations with age in the mechanical properties of human skin in vivo.
GB0617451D0 (ja)
WO2006133149A3 (en) Method for analyzing power consumption of circuit design using hardware emulation
GB2468045A (en) Method for reservoir characterization and monitoring including deep reading quad combo measurements
ATE431097T1 (de) Verfahren und vorrichtung für die analyse einer flüssigkeit
RU2013114331A (ru) Способы и системы для оцеки психологических характеристик
WO2006072004A3 (en) Method and apparatus for analyte measurement test time
WO2007020598A3 (en) Method and apparatus featuring simple click style interactions according to a clinical task workflow
CN109918833A (zh) 一种数值模拟可信度的定量分析方法
GB201015230D0 (en) A method and system for managing analytical quality in networked laboratories
Ramalho Regression models for choice-based samples with misclassification in the response variable
WO2005119565A3 (en) System and method for inspecting articles of manufacture
Odenwald Test methods in the development of sports equipment
WO2008051660A3 (en) Apparatus and method for computer modeling chemical sensitivity of skin
Wang et al. Uncertainty quantification in low cycle fatigue life model based on Bayesian theory
Popescu et al. Relations between learning style and learner behavior in an educational hypermedia system: An exploratory study
He et al. Using the dichotomous Rasch model to analyze polytomous items
Fu et al. Patent lifespan prediction and interpreting the key determinants: An application of interpretable machine learning survival analysis approach
WO2008157566A3 (en) Computerized evaluation of user impressions of product artifacts
Doostparast et al. Statistical evidence methodology for model acceptance based on record values
Walker Estimating how many observations are needed to obtain a required level of reliability